Background. Detection of circulating malignant thyroid cells may provi
de a method to identify postoperative patients at risk for metastatic
thyroid cancer. Methods. On the basis of tissue specificity of thyrogl
obulin gene expression and the sensitivity of the reverse transcriptas
e-polymerase chain reaction (RT-PCR) analysis, we performed RT-PCR usi
ng primers for thyroglobulin on blood samples from patients with thyro
id disease to detect thyroglobulin RNA transcripts. Postoperative peri
pheral blood samples from 100 patients, including patients with known
metastatic thyroid cancer (six papillary and three follicular), thyroi
d cancer and no evidence of current metastases (63 papillary, 10 folli
cular, and five patients with both papillary and follicular), benign t
hyroid disease (six nontoxic, nodular goiters), and normal volunteers
(seven). Results. Thyroglobulin transcripts were detected in nine of n
ine patients with metastatic thyroid cancer, seven of 78 patients with
thyroid cancer and no current metastases (although of these seven pat
ients, five had a history of metastatic disease that had been previous
ly treated by surgery, one had a coexisting parathyroid cancer, and on
e had both papillary and follicular thyroid cancers), zero of six pati
ents with benign thyroid disease, and zero of seven normal volunteers.
Identity of amplicons was confirmed by restriction enzyme digestion a
nd by cloning and sequencing of RT-PCR amplified thyroglobulin fragmen
t (the latter in a limited number of cases). Conclusions. These data i
ndicate that RT-PCR can be used to detect thyroglobulin mRNA in periph
eral blood. The presence of these transcripts correlates with the exis
tence of extrathyroidal disease.